Expression profiling of endomyocardial tissues from 3 subjects before, during, and after a rejection episode. Cardiac allograft rejection is a significant clinical problem in the early phase after heart transplantation and requires frequent surveillance with endomyocardial biopsy.
GPL96:
[HG-U133A] Affymetrix Human Genome U133A Array
Citation:
Karason K, Jernås M, Hägg DA, Svensson PA. Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection. BMC Cardiovasc Disord 2006 Jun 19;6:29. PMID: 16780603
